• LAST PRICE
    0.2650
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (3.9216%)
  • Bid / Lots
    0.2600/ 50
  • Ask / Lots
    0.2700/ 11
  • Open / Previous Close
    0.2550 / 0.2550
  • Day Range
    Low 0.2400
    High 0.2650
  • 52 Week Range
    Low 0.2000
    High 0.6000
  • Volume
    32,500
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.255
TimeVolumeAVCN
09:32 ET5000.255
09:33 ET20000.255
09:37 ET10000.255
09:39 ET40000.24
10:38 ET45000.255
12:06 ET25000.26
12:08 ET160000.26
02:48 ET10000.265
03:51 ET10000.265
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaAVCN
Avicanna Inc
27.9M
-3.7x
---
CanadaMBX
Microbix Biosystems Inc
42.0M
8.1x
---
CanadaCSCI
COSCIENS Biopharma Inc
15.5M
-0.4x
---
CanadaMPH
Medicure Inc
9.2M
-3.5x
---
CanadaNUMI
Numinus Wellness Inc
12.9M
-0.6x
---
CanadaSZLS
StageZero Life Sciences Ltd
4.9M
0.0x
---
As of 2024-11-22

Company Information

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.

Contact Information

Headquarters
480 UNIVERSITY AVENUE, SUITE 1502TORONTO, ON, Canada M5G 1V2
Phone
647-243-5283
Fax
647-243-5283

Executives

Chief Executive Officer, Director
Aras Azadian
Chief Financial Officer
Phillip Cardella
Executive Vice President - Marketing
Ivana Maric
Executive Vice President - Medical Affairs
Karolina Urban
Chief Legal Officer, General Counsel, & Corporate Secretary of Avicanna USA Inc
Stephen Kim

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$29.0M
Revenue (TTM)
$24.9M
Shares Outstanding
109.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.49
EPS
$-0.07
Book Value
$0.00
P/E Ratio
-3.7x
Price/Sales (TTM)
1.2
Price/Cash Flow (TTM)
---
Operating Margin
-25.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.